WT1 peptide vaccination combined with BCG-CWS is more efficient for tumor eradication than WT1 peptide vaccination alone

Cancer Immunology, Immunotherapy

Volumn 53, Issue 7, 2004, Pages 617-624

  Nakajima, Hiroko ^a   Kawasaki, Kotomi ^a   Oka, Yoshihiro ^b   Tsuboi, Akihiro ^b   Kawakami, Manabu ^b   Ikegame, Kazuhiro ^b   Hoshida, Yoshihiko ^b   Fujiki, Fumihiro ^a   Nakano, Akiko ^b   Masuda, Tomoki ^b   Wu, Fei ^b   Taniguchi, Yuki ^b   Yoshihara, Satoshi ^b   Elisseeva, Olga A ^a   Oji, Yusuke ^a   Ogawa, Hiroyasu ^b   Azuma, Ichiro ^c   Kawase, Ichiro ^b   Aozasa, Katsuyuki ^b   Sugiyama, Haruo ^a  

^a OSAKA UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^c HAKODATE NATIONAL COLLEGE OF TECHNOLOGY   (Japan)

Author keywords

BCG CWS; Immunotherapy; Wilms' tumor gene; WT1

Indexed keywords

BCG VACCINE; WT1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER THERAPY; CONTROLLED STUDY; CYTOTOXICITY; IMMUNE RESPONSE; LEUKEMIA; LUNG CARCINOMA; MALE; MOUSE; MYCOBACTERIUM BOVIS; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TUMOR CELL; VACCINATION;

ANIMALS; BONE MARROW; CANCER VACCINES; COLONY-FORMING UNITS ASSAY; IMMUNOTHERAPY; KIDNEY; LEUKEMIA; LIPOPOLYSACCHARIDES; LUNG NEOPLASMS; MALE; MICE; MICE, INBRED C57BL; PEPTIDE FRAGMENTS; T-LYMPHOCYTES, CYTOTOXIC; TUMOR CELLS, CULTURED; VACCINATION; WT1 PROTEINS;

EID: 3042720809     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00262-003-0498-0     Document Type: Article

References (40)

1. Azuma I, Yamamura Y (1979) Immunotherapy of cancer with BCG cell wall skeleton and related materials. Gann Monograph Cancer Res 24:121-141
2. Banchereau J, Briere F, Caux C, Davoust J, Lebecque S, Liu YJ, Pulendran B, Palucka K (2000) Immunobiology of dendritic cells. Annu Rev Immunol 18:767-811
3. Briegar J, Weidmann E, Fenchel K, Mitrou PS, Hoelzer D, Bergmann L (1994) The expression of the Wilms' tumor gene in acute myelocytic leukemias as a possible marker for leukemic blast cells. Leukemia 8:2138
4. Buckler AJ, Pelletier J, Haber DA, Glaser T, Housman DE (1991) Isolation, characterization, and expression of the murine Wilms' tumor gene (WT1) during kidney development. Mol Cell Biol 11:1707
5. Call KM, Glaser T, Ito CY, Buckler AJ, Pelletier J, Haber DA, Rose EA, Kral A, Yeger H, Lewis WH, Jones C, Housman DE (1990) Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms' tumor locus. Cell 60:509
6. Davies R, Moore A, Schedl A, Bratt E, Miyahawa K, Ladomery M, Mile C, Menke A, van Heyningen V, Hastie N (1999) Multiple roles for the Wilms' tumor suppressor, WT1. Cancer Res 59[Suppl 7]:1747, 1751
7. Fausch SC, Da Silva DM, Kast WM (2003) Differential uptake and cross-presentation of human papillomavirus virus-like particles by dendritic cells and langerhans cells. Cancer Res 63:3478-3482
8. Gessler M, Poustka A, Cavenee W, Nevel RL, Orkin SH, Bruns GA (1990) Homozygous deletion in Wilms tumors of a zinc-finger gene identified by chromosome jumping. Nature 343:774
9. + progenitor cells by cytotoxic T lymphocytes specific for WT1. Blood 95:2198
10. Hayashi A, Doi O, Azuma I, Toyoshima K (1998) Immuno-friendly use of BCG-cell wall skeleton remarkably improves the survival rate of various cancer patients. Proc Jpn Acad 70:205
11. Hirahashi T, Matsumoto M, Hazeki K, Saeki Y, Ui M, Seya T (2002) Activation of the human innate immune system by Spirulina: augmentation of interferon production and NK cytotoxicity by oral administration of hot water extract of Spirulina platensis. Int Immunopharmacol 2:423
12. + haematopoetic progenitor cells express the Wilms' tumor gene WT1 at levels similar to those in leukemia cells. Br J Haematol 116:409
13. Inoue K, Sugiyama H, Ogawa H, Nakagawa M, Yamagami T, Miwa H, Kita K, Hiraoka A, Masaoka T, Nasu K, Kyo T, Dohy H, Nakauchi H, Ishidate T, Akiyama T, Kisimoto T (1994) WT1 as a new prognostic factor and a new marker for the detection of minimal residual disease in acute leukemia. Blood 84:3071
14. Inoue K, Ogawa H, Sonoda Y, Kimura T, Sakabe H, Oka Y, Miyake S, Tamaki H, Oji Y, Yamagami T, Tatekawa T, Soma T, Kishimoto T, Sugiyama H (1997) Aberrant overexpression of the Wilms' tumor gene (WT1) in human leukemia. Blood 89:1405
15. Inoue K, Tamaki H, Ogawa H, Oka Y, Soma T, Tatekawa T, Oji Y, Tsuboi A, Kim EH, Kawakami M, Akiyama T, Kishimoto T, Sugiyama H (1998) Wilms' tumor gene (WT1) competes with differentiation-inducing signal in hematopoietic progenitor cells. Blood 91:2969
16. Lamm DL, Blumenstein BA, Crawford ED, Montie JE, Scardino P, Grossman HB, Stanisic TH, Smith JA Jr, Sullivan J, Sarosdy MF, Crissman JD, Coltman CA (1991) A randomized trial of intravesical doxorubicin and immunotherapy with Bacille Calmette-Guérin for transitional-cell carcinoma of the bladder. N Engl J Med 325:1205
17. Lipton A, Harvey HA, Lawrence B, Gottlieb R, Kukrika M, Dixon R, Graham W, Miller S, Heckard R, Schelzel D, White DS (1983) Corynebacterium parvum versus BCG adjuvant immunotherapy in human malignant melanoma. Cancer 51:57
18. Lipton A, Harvey HA, Balch CM, Antle CE, Heckard R, Bartolucci AA (1991) Corynebacterium parvum versus Bacille Calmette-Guérin adjuvant immunotherapy of stage II malignant melanoma. J Clin Oncol 9:1551
19. Loeb DM, Evron E, Patel CB, Sharma PM, Niranjan B, Buluwela L, Weitzman SA, Korz D, Sukumar S (2001) Wilms' tumor suppressor gene (WT1) is expressed in primary breast tumors despite tumor-specific promotor methylation. Cancer Res 61:921
20. Matsumoto M, Seya T, Kikkawa S, Tsuji S, Shida K, Nomura M, Kurita-Taniguchi M, Ohigashi H, Yokouchi H, Takami H, Hayashi A, Azuma I, Masaoka T, Kodama K, Toyoshima K (2001) Interferon gamma-producing ability in blood lymphocytes of patients with lung cancer through activation of the innate immune system by BCG cell wall skeleton. Int Immunopharmacol 1:1559
21. Menke AL, Van der Eb AJ, Jochemsen AG (1998) The Wilms' tumor 1 gene: oncogene or tumor suppressor gene? Int Rev Cytol 181:151
22. Menssen HD, Renkl HJ, Rodeck U, Maurer J, Notter M, Schwarz S, Reinhardt R, Thiel E (1995) Presence of Wilms' tumor gene (WT1) transcripts and the WT1 nuclear protein in the majority of human acute leukemias. Leukemia 9:1060
23. Miwa H, Beran M, Saunders GF (1992) Expression of the Wilms' tumor gene (WT1) in human leukemias. Leukemia 6:405
24. Miyagi T, Ahuja H, Kubota T, Kubonishi I, Koeffler HP, Miyoshi I (1993) Expression of the candidate Wilms' tumor gene, WT1, in human leukemia cells. Leukemia 7:970
25. Ochiai T, Sato H, Hayashi R, Asano T, Sato H, Yamamura Y (1983) Postoperative adjuvant immunotherapy of gastric cancer with BCG-cell wall skeleton. 3- to 6-year follow up of a randomized clinical trial. Cancer Immunol Immunother 14:167
26. + cytotoxic T-lymphocyte clone specific for WT1 peptide. Blood 95:286
27. Oji Y, Ogawa H, Tamaki H, Oka Y, Tsuboi A, Kim EH, Soma T, Tatekawa T, Kawakami M, Asada M, Kishimoto T, Sugiyama H (1999) Expression of the Wilms' tumor gene WT1 in solid tumors and its involvement in tumor cell growth. Jpn J Cancer Res 90:194
28. Oji Y, Miyoshi S, Maeda H, Hayashi S, Tamaki H, Nakatsuka S, Yao M, Takahashi E, Nakano Y, Hirabayashi H, Shintani Y, Oka Y, Tsuboi A, Hosen N, Asada M, Fujioka T, Murakami M, Kanato K, Motomura M, Kim EH, Kawakami M, Ikegame K, Ogawa H, Aozasa K, Kawase I, Suigiyama H (2002) Overexpression of the Wilms' tumor gene WT1 in de novo lung cancers. Int J Cancer 100:297
29. Oka Y, Elisseeva OA, Tsuboi A, Ogawa H, Tamaki H, Li H, Oji Y, Kim EH, Soma T, Asada M, Ueda K, Maruya E, Saji H, Kishimoto T, Udaka K, Sugiyama H (2000) Human cytotoxic T-lymphocyte response specific for peptides of the wild-type Wilms' tumor gene (WT1) product. Immunogenetics 51:99
30. Oka Y, Udaka K, Tsuboi A, Elisseeva OA, Ogawa H, Aozasa K, Kishimoto T, Sugiyama H (2000) Cancer immunotherapy targeting Wilms' tumor gene WT1 product. J Immunol 164:1873
31. Park S, Schalling M, Bernard A, Maheswaran S, Shipley GC, Roberts D, Fletcher J, Shipman R, Rheinwald J, Demetri G, Griffin J, Minden M, Housman DE, Haber DA (1993) The Wilms tumor gene WT1 is expressed in murine mesoderm-derived tissues and mutated in a human mesothelioma. Nature Genet 4:415
32. Sugiyama H (2002) Cancer immunotherapy targeting WT1 protein. Int J Hematol 76:127
33. Thurnher M, Ramoner R, Gastl G, Radmayr C, Bock G, Herold M, Klocker H, Bartsch G. (1997) Bacillus Calmette-Guérin mycobacteria stimulate human blood dendoritic cells. Int J Cancer 70:128
34. Tsuboi A, Oka Y, Ogawa H, Elisseeva OA, Tamaki H, Oji Y, Kim EH, Soma T, Tatekawa T, Kawakami M, Kishimoto T, Sugiyama H (1999) Constitutive expression of the Wilms' tumor gene WT1 inhibits the differentiation of myeloid progenitor cells but promotes their proliferation in response to granulocyte-colony stimulating factor (G-CSF). Leuk Res 23:499
35. Tsuboi A, Oka Y, Ogawa H, Elisseeva OA, Li H, Kawasaki K, Aozasa K, Kishimoto T, Udaka K, Sugiyama H (2000) Cytotoxic T-lymphocyte responses elicited to Wilms' tumor gene WT1 product by DNA vaccination. J Clin Immunol 20:195
36. Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, Hayashi A, Toyoshima K, Seya T (2000) Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis bacillus Calmette-Guérin: involvement of toll-like receptors. Infect Immun 68:6883
37. Veronesi U, Adamus J, Aubert C, Bajetta E, Beretta G, Bonadonna G, Bufalino R, Cascinelli N, Cocconi G, Durand J, De Marsillac J, Ikonopisov RL, Kiss B, Lejeune F, MacKie R, Madej G, Mulder H, Mechl Z, Milton GW, Morabito A, Peter H, Priario J, Paul E, Rumke P, Sertoli R, Tomin R (1982) A randomized trial of adjuvant chemotherapy and immunotherapy in cutaneous melanoma. N Engl J Med 307:913
38. Yamagami T, Sugiyama H, Inoue K, Ogawa H, Tatekawa T, Hirata M, Kudoh T, Akiyama T, Murakami A, Maekawa T, Kisimoto T (1996) Growth inhibition of human leukemic cells by WT1 (Wilms tumor gene) antisense oligonucleotides: Implications for the involvement of WT1 in leukemogenesis. Blood 87:2878
39. Yamamura Y, Sakatani M, Ogura T, Azuma I (1979) Adjuvant immunotherapy of lung cancer with BCG cell wall skeleton (BCG-CWS). Cancer 43:1314
40. Yasumoto K, Manabe H, Yanagawa E, Nagano N, Ueda H, Hirota N, Ohta M, Nomoto K, Azuma I, Yamamura Y (1979) Nonspecific adjuvant immunotherapy of lung cancer with cell wall skeleton of Mycobacterium bovis Bacillus Calmette-Guérin. Cancer Res 39:3262